GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Replek AD (XMAE:REPL) » Definitions » 3-Year EPS without NRI Growth Rate

Replek AD (XMAE:REPL) 3-Year EPS without NRI Growth Rate : 17.60% (As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Replek AD 3-Year EPS without NRI Growth Rate?

Replek AD's EPS without NRI for the three months ended in Dec. 2024 was MKD684.10.

During the past 12 months, Replek AD's average EPS without NRI Growth Rate was -52.70% per year. During the past 3 years, the average EPS without NRI Growth Rate was 17.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was 16.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was 6.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Replek AD was 47.20% per year. The lowest was -32.60% per year. And the median was 9.05% per year.


Competitive Comparison of Replek AD's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Replek AD's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Replek AD's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Replek AD's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Replek AD's 3-Year EPS without NRI Growth Rate falls into.


;
;

Replek AD 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Replek AD  (XMAE:REPL) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Replek AD 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Replek AD's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Replek AD Business Description

Industry
Traded in Other Exchanges
N/A
Address
Kozle 188, Skopje, MKD
Replek AD is engaged in the development, design and production of generic medicines. The company develops drugs in different pharmaceutical therapeutic categories including anti-platelet, lipid-lowering, atypical antipsychotic, anti-infective, among others. It manufactures drugs in different forms including tablets, capsules, oral solutions, creams and ointments. Its product portfolio consists of Clopidogrel, Atorvastatin, Simvastatin, risperidone, Clarythromycin, Ciprofloxacin, Meloksikam, Risperidon, terazosin, among others. Replek also offers cannabis oil products, food supplements and cosmetics.